Combined radiation and chemotherapy for unresectable non-small cell lung carcinoma.
Bleehen
N M
NM
Ball
D
D
Belani
C P
CP
Bishop
J
J
Douillard
J Y
JY
Cox
J D
JD
Johnson
D H
DH
Le Chevalier
T
T
Saunders
M I
MI
Shaw
E
E
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy / Q000628:therapy*; D017322:Clinical Trials, Phase II as Topic / Q000379:methods / Q000592:standards*; D017326:Clinical Trials, Phase III as Topic / Q000379:methods / Q000592:standards*; D003131:Combined Modality Therapy; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy / Q000628:therapy*; D009367:Neoplasm Staging; D011878:Radiotherapy / Q000009:adverse effects; D016019:Survival Analysis; D016896:Treatment Outcome
D000970:Antineoplastic Agents